Fang Fang Zhang1, Danielle E Haslam1, Mary Beth Terry2, Julia A Knight3,4, Irene L Andrulis3,4, Mary B Daly5, Saundra S Buys6, Esther M John7,8. 1. Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts. 2. Mailman School of Public Health, Columbia University, New York, New York. 3. Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. 4. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 5. Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 6. Huntsman Cancer Institute at the University of Utah Health Sciences Center, Salt Lake City, Utah. 7. Cancer Prevention Institute of California, Fremont, California. 8. Department of Health Research and Policy (Epidemiology) and Stanford Cancer Institute, Stanford University of School of Medicine, Stanford, California.
Abstract
BACKGROUND: Soy foods possess both antiestrogenic and estrogen-like properties. It remains controversial whether women diagnosed with breast cancer should be advised to eat more or less soy foods, especially for those who receive hormone therapies as part of cancer treatment. METHODS: The association of dietary intake of isoflavone, the major phytoestrogen in soy, with all-cause mortality was examined in 6235 women with breast cancer enrolled in the Breast Cancer Family Registry. Dietary intake was assessed using a Food Frequency Questionnaire developed for the Hawaii-Los Angeles Multiethnic Cohort among 5178 women who reported prediagnosis diet and 1664 women who reported postdiagnosis diet. Cox proportional-hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: During a median follow-up of 113 months (approximately 9.4 years), 1224 deaths were documented. A 21% decrease was observed in all-cause mortality for women who had the highest versus lowest quartile of dietary isoflavone intake (≥1.5 vs < 0.3 mg daily: HR, 0.79; 95% confidence interval CI, 0.64-0.97; Ptrend = .01). Lower mortality associated with higher intake was limited to women who had tumors that were negative for hormone receptors (HR, 0.49; 95% CI, 0.29-0.83; Ptrend = .005) and those who did not receive hormone therapy for their breast cancer (HR, 0.68; 95% CI, 0.51-0.91; Ptrend = .02). Interactions, however, did not reach statistical significance. CONCLUSIONS: In this large, ethnically diverse cohort of women with breast cancer living in North America, a higher dietary intake of isoflavone was associated with reduced all-cause mortality. Cancer 2017;123:2070-2079.
BACKGROUND: Soy foods possess both antiestrogenic and estrogen-like properties. It remains controversial whether women diagnosed with breast cancer should be advised to eat more or less soy foods, especially for those who receive hormone therapies as part of cancer treatment. METHODS: The association of dietary intake of isoflavone, the major phytoestrogen in soy, with all-cause mortality was examined in 6235 women with breast cancer enrolled in the Breast Cancer Family Registry. Dietary intake was assessed using a Food Frequency Questionnaire developed for the Hawaii-Los Angeles Multiethnic Cohort among 5178 women who reported prediagnosis diet and 1664 women who reported postdiagnosis diet. Cox proportional-hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: During a median follow-up of 113 months (approximately 9.4 years), 1224 deaths were documented. A 21% decrease was observed in all-cause mortality for women who had the highest versus lowest quartile of dietary isoflavone intake (≥1.5 vs < 0.3 mg daily: HR, 0.79; 95% confidence interval CI, 0.64-0.97; Ptrend = .01). Lower mortality associated with higher intake was limited to women who had tumors that were negative for hormone receptors (HR, 0.49; 95% CI, 0.29-0.83; Ptrend = .005) and those who did not receive hormone therapy for their breast cancer (HR, 0.68; 95% CI, 0.51-0.91; Ptrend = .02). Interactions, however, did not reach statistical significance. CONCLUSIONS: In this large, ethnically diverse cohort of women with breast cancer living in North America, a higher dietary intake of isoflavone was associated with reduced all-cause mortality. Cancer 2017;123:2070-2079.
Authors: Sarah J Nechuta; Bette J Caan; Wendy Y Chen; Wei Lu; Zhi Chen; Marilyn L Kwan; Shirley W Flatt; Ying Zheng; Wei Zheng; John P Pierce; Xiao Ou Shu Journal: Am J Clin Nutr Date: 2012-05-30 Impact factor: 7.045
Authors: Patricia M Guenther; Sharon I Kirkpatrick; Jill Reedy; Susan M Krebs-Smith; Dennis W Buckman; Kevin W Dodd; Kellie O Casavale; Raymond J Carroll Journal: J Nutr Date: 2014-01-22 Impact factor: 4.798
Authors: Bette J Caan; Loki Natarajan; Barbara Parker; Ellen B Gold; Cynthia Thomson; Vicky Newman; Cheryl L Rock; Minya Pu; Wael Al-Delaimy; John P Pierce Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-02-25 Impact factor: 4.254
Authors: D O Stram; J H Hankin; L R Wilkens; M C Pike; K R Monroe; S Park; B E Henderson; A M Nomura; M E Earle; F S Nagamine; L N Kolonel Journal: Am J Epidemiol Date: 2000-02-15 Impact factor: 4.897
Authors: Brian N Fink; Susan E Steck; Mary S Wolff; Julie A Britton; Geoffrey C Kabat; Mia M Gaudet; Page E Abrahamson; Paula Bell; Jane C Schroeder; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11 Impact factor: 4.254
Authors: Yukiko Morimoto; Gertraud Maskarinec; Song-Yi Park; Reynolette Ettienne; Rayna K Matsuno; Camonia Long; Alana D Steffen; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand; Lynne R Wilkens Journal: Br J Nutr Date: 2014-09-28 Impact factor: 3.718
Authors: Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara Journal: Breast Cancer Res Date: 2004-05-19 Impact factor: 6.466
Authors: Ioannis Boutas; Adamantia Kontogeorgi; Constantine Dimitrakakis; Sophia N Kalantaridou Journal: In Vivo Date: 2022 Mar-Apr Impact factor: 2.155
Authors: Benedikt Warth; Philipp Raffeiner; Ana Granados; Tao Huan; Mingliang Fang; Erica M Forsberg; H Paul Benton; Laura Goetz; Caroline H Johnson; Gary Siuzdak Journal: Cell Chem Biol Date: 2018-01-11 Impact factor: 8.116